Key result
Remifentanil pretreatment blunts the TpTe/RR ratio increase by ~24% vs saline during electroconvulsive therapy.
Why the study?
QT interval dispersion increases during ECT, and this study aimed to evaluate the effect of remifentanil on TpTe, a marker of transmural dispersion of ventricular repolarization, during ECT.
Does remifentanil reduce the transmural dispersion of ventricular repolarization (TpTe) in patients undergoing electroconvulsive therapy?
RCT (n=42)
Randomly assigned
No
Does remifentanil reduce the transmural dispersion of ventricular repolarization (TpTe) in patients undergoing electroconvulsive therapy?
Pretreatment with remifentanil suppressed the increase in the TpTe/RR interval after electrical stimulation during electroconvulsive therapy, suggesting it may attenuate transmural dispersion of ventricular repolarization.
Answers are grounded in this paper and cite their sources.
Remifentanil attenuates post-stimulation TpTe/RR rise during ECT; extends RCT evidence on repolarization effects to this setting.
INTRODUCTION: QT interval dispersion, which reflects the regional heterogeneity of ventricular repolarization, increases during electroconvulsive therapy (ECT). Tpeak-Tend (TpTe) is considered a new marker of the transmural dispersion of ventricular repolarization (TDR). This study aimed to evaluate the effect of remifentanil on TpTe during ECT. METHODS: √RR every minute during ECT (QT: QT interval, QTc: corrected QT interval, RR: RR interval). Statistical analysis was performed using two-way analysis of variance (ANOVA). RESULTS: Immediately (T0) and 1 min (T1) after electrical stimulation, the RRs (group C: T0; 654.2 ± 145.9 ms, T1; 657.3 ± 114.8 ms, group R: T0; 849.6 ± 249.3 ms, T1; 885.4 ± 213.6 ms, p < 0.05) were significantly increased, while systolic (group C: T0; 177.1 ± 35 mmHg, group R: T0; 129 ± 27.2 mmHg, p < 0.05) and diastolic blood pressures (group C: T0; 107.1 ± 22.4 mmHg, T1; 101.3 ± 23.2 mmHg, group R: T0; 75.4 ± 19.3 mmHg, T1; 80.6 ± 18.3 mmHg, p < 0.05) were significantly decreased in group R compared to group C. The TpTe/RR was significantly lower at T1 in group R compared to group C (group C: 101.5 ± 28.2, group R: 76.8 ± 21.8, p < 0.05). However, there was no significant difference in TpTe, TpTe/QT, TpTe/QTc, TpTe/√RR or TpTe/3√RR between the two groups throughout the study. CONCLUSION: Pretreatment with remifentanil suppressed the increase of TpTe/RR after electrical stimulation. Our results imply that remifentanil may lead to a decrease in TDR during ECT. TRIAL REGISTRATION: This trial was registered with the University Hospital Medical Information Network (registration number: UMIN000051958).
No takes yet. Share an insight, caveat, or question.
Eda et al. (2023) conducted an RCT in Psychiatric disorders requiring electroconvulsive therapy (n=42). Remifentanil vs. Saline (placebo) was evaluated on TpTe/RR ratio at 1 minute after electrical stimulation (T1) (p=<0.05). Pretreatment with remifentanil suppressed the increase in the TpTe/RR ratio at 1 minute after electrical stimulation during electroconvulsive therapy compared to saline.
Synapse has enriched 10 related papers. Consider them for comparative context: